Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care
NCT ID: NCT06153589
Last Updated: 2025-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
180 participants
INTERVENTIONAL
2025-01-08
2026-09-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The prevalence of leg ulcers is estimated at 1% of the general population and 3% to 5% of subjects over 65 years old. Its prevalence increases with age in both men and women.
Managing chronic ulcers requires a certain number of care procedures, including debridement.
The act of treatment by mechanical debridement is little relieved by the analgesics given beforehand, and can be painful, with risks of bleeding.
Musicotherapy, particularly the U-shaped method, has shown its effectiveness in the treatment of pain and anxiety in several areas (geriatrics, intensive care, rheumatology, oncology, etc.).
The standardized musicotherapy method of the U-shaped sequence was developed and initially evaluated by clinical studies coordinated by the INSERM unit U1061 (Pr. Jacques Touchon; Dr. Stéphane Guétin).
Following the publication of numerous controlled, randomized studies presenting results on the effectiveness in the treatment of pain and anxiety, a digital application was developed in order to standardize the method. The Music Care health application is now a Class 1 Medical Device, with CE marking obtained.
This "U-shaped sequence" is standardized and has been clinically validated, which makes Music Care a unique tool available for pain relief.
No studies have been found in the literature regarding the use of music therapy during debridement care.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Musicotherapy + debridement and usual analgesic protocol
Patients in the experimental arm will receive classic debridement care and usual use of analgesic treatment, accompanied by a musicotherapy session respecting the standardized method of the U-shaped sequence.
Musicotherapy
Musicotherapy will be offered to patients who meet the eligibility criteria, and have been randomized to the experimental arm.
Patients will only be seen once during the study. Patients are placed in individual rooms. Hifi audio headphones (equipped with hygienic earcups) and a tablet equipped with the Music Care application will be offered to patients in the experimental group and the investigators will help them choose the style of music, which respects the U-shaped sequence.
The Music Care application has proven that the use of headphones allows the patient to be isolated and therefore to obtain less parasitic care. He will be told at the start of the session that he can ask to interrupt it if he wishes to communicate with the team, particularly regarding possible pain.
The musicotherapy session begins before the act of debridement (10 minutes before), lasts during the act (40 minutes maximum), and continues for 10 minutes after the end of the debridement.
Debridement and usual analgesic protocol
Patients in the experimental arm will receive classic debridement care and usual use of analgesic treatment.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Musicotherapy
Musicotherapy will be offered to patients who meet the eligibility criteria, and have been randomized to the experimental arm.
Patients will only be seen once during the study. Patients are placed in individual rooms. Hifi audio headphones (equipped with hygienic earcups) and a tablet equipped with the Music Care application will be offered to patients in the experimental group and the investigators will help them choose the style of music, which respects the U-shaped sequence.
The Music Care application has proven that the use of headphones allows the patient to be isolated and therefore to obtain less parasitic care. He will be told at the start of the session that he can ask to interrupt it if he wishes to communicate with the team, particularly regarding possible pain.
The musicotherapy session begins before the act of debridement (10 minutes before), lasts during the act (40 minutes maximum), and continues for 10 minutes after the end of the debridement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient followed at the M@diCICAT healing center requiring wound debridement :
* For a venous or arterial ulcer or necrotizing angiodermatitis of the lower limbs,
* Having the ability to verbalize about their pain (communicating),
* With a planned debridement time of less than 40 minutes.
* Patient affiliated to or beneficiary of a social security scheme,
* Patient having given free, informed and express consent.
Exclusion Criteria
* Patient not requiring a debridement session,
* Patient with an infected ulcer (abscess, etc.),
* Patient with critical ischemia,
* Patient with hearing problems,
* Patient with cognitive disorders,
* Patient placed under legal protection, guardianship or curatorship,
* Pregnant or breastfeeding woman.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Music Care
UNKNOWN
University Hospital Center of Martinique
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emmanuelle Guitteaud
Role: PRINCIPAL_INVESTIGATOR
University Hospital Center of Martinique
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Center of Martinique
Fort-de-France, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yann Mopsus, MSc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23_RIPH2-10
Identifier Type: -
Identifier Source: org_study_id